Thiazolo[4,5-d]pyrimidines. Part II. Synthesis and anti-human cytomegalovirus activity in vitro of certain acyclonucleosides and acyclonucleotides derived from the guanine analogue 5-aminothiazolo[4,5-d]pyrimidine-2,7(3H,6H)-dione

Antiviral Chemistry and Chemotherapy

Volumn 9, Issue 1, 1998, Pages 53-63

  Revankar, G R ^a   Ojwang, J O ^a   Mustain, S D ^a   Rando, R F ^a   De Clercq, E ^b   Huffman, J H ^c   Drach, J C ^d   Sommadossi, J P ^e   Lewis, A F ^a  

^a Aronex Pharmaceuticals   (United States)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c UTAH STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e University of Alabama at Birmingham   (United States)

Author keywords

Acyclonucleoside; Human cytomegalovirus; Thiazolo 4,5 d pyrimidine

Indexed keywords

5 AMINOTHIAZOLO[4,5 D]PYRIMIDINE 2,7(3H,6H) DIONE; ACYCLIC NUCLEOSIDE; ANTIVIRUS AGENT; GANCICLOVIR; GUANINE DERIVATIVE; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IN VITRO STUDY; PRIORITY JOURNAL; VIRUS REPLICATION;

EID: 0031963957     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029800900102     Document Type: Article

References (42)

1. Ashton WT, Meurer LC, Cantone CL, Field AK, Hannah J, Karkas JD, Liou R, Patel GF, Perry HC, Wagner AF, Walton E & Tolman RL (1988) Synthesis and antiherpetic activity of(±)-9-[[(Z)-2-(hydroxymethyl)cyclopropyl]methyl]guanine and related compounds. Journal of Medicinal Chemistry 31:2304-2315.
2. Baker JA & Chatfield PV (1970) Synthesis of derivatives of thiazolo[4,5-d]pyrimidine. Part II. Journal of the Chemical Society Section C Organic Chemistry, 2478-2484.
3. Balfour Jr HH (1990) Management of cytomegalovirus disease with antiviral drugs. Reviews of Infectious Diseases 12:S849-S860.
4. Beauchamp LM, Serling BL, Kelsey JE, Biron KK, Collins P, Selway J, Lin J-C & Schaeffer HJ (1988) Effect of acyclic pyrimidines related to 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine on herpesviruses. Journal of Medicinal Chemistry 31:144-149.
5. Bhattacharya BK, Ojwang JO, Rando RF, Huffman JH & Revankar GR (1995) Synthesis and anti-DNA viral activities in vitro of certain 2,4-disubstituted-7-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)pyrrolo[2,3-d] pyrimidine nucleosides. Journal of Medicinal Chemistry 38:3957-3966.
6. Biron KK (1991) Ganciclovir-resistant human cytomegalovirus clinical isolates: resistance mechanisms and in vitro susceptibility to antiviral agents. Transplant Proceedings 23:162-167.
7. Chrisp P & Clissold SP (1991) Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Drugs 41:104-129.
8. Chu CK & Cutler SJ (1986) Chemistry and antiviral activities of acyclonucleosides. Journal of Heterocyclic Chemistry 23:289-319.
9. Collaborative DHPG Treatment Study Group (1986) Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies. New England Journal of Medicine 314:801-805.
10. De Clercq E (1994) Antiviral activity spectrum and target of action of different classes of nucleoside analogues. Nucleosides and Nucleotides 13:1271-1295.
11. Derse D, Cheng Y-C, Furman PA, St Clair MH & Elion GB (1981) Inhibition of purified human and herpes simplex virus-induced DNA polymerases by 9-(2-hydroxyethoxymethyl)guanine triphosphate. Journal of Biological Chemistry 256:11447-11451.
12. Drew WL, Miner RC, Busch DF, Follansbee SE, Gullet J, Mehalko SG, Gordon SM, Owen Jr WF, Mattthews TR, Buhles WC & DeArmond B (1991) Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. Journal of Infectious Diseases 163:716-719.
13. Elion GB (1982) Mechanism of action and selectivity of acyclovir. American Journal of Medicine 73:7-13.
14. Elion GB (1983) The biochemistry and mechanism of action of acyclovir. Journal of Antimicrobial Chemotherapy 12 (Supplement B):9-17.
15. Haines DR, Tseng CKH & Marquez VE (1987) Synthesis and biological activity of unsaturated carboacyclic purine nucleoside analogues. Journal of Medicinal Chemistry 30:943-947.
16. Halazy S, Danzin C & Nave J-F (1991) Novel unsaturated acyclic phosphonate derivatives of purine and pyrimidine. European Patent Application 91402427.8.
17. Harnden MR, Parkin A, Parratt MJ & Perkins RM (1993) Novel acyclonucleotides: synthesis and antiviral activity of alkenylphosphonic acid derivatives of purines and a pyrimidine. Journal of Medicinal Chemistry 36:1343-1355.
18. Herdewijn PAMM (1992) Novel nucleoside strategies for anti-HIV and anti-HSV therapy. Antiviral Research 19:1-14.
19. Hua M, Korkowski PM & Vince R (1987) Synthesis and biological evaluation of acyclic neplanocin analogues. Journal of Medicinal Chemistry 34:198-200.
20. Jacobson MA (1992) Review of the toxicities of foscarnet. Journal of Acquired Immune Deficiency Syndromes 5:S11-S17.
21. Jacobson MA, Drew WL, Feinberg J, O'Donnell JJ, Whitmore PV, Miner RD & Parenti D (1991) Foscarnet therapy for ganciclovirresistant cytomegalovirus retinitis in patients with AIDS. Journal of Infectious Diseases 163:1348-1351.
22. Johansson NG (1993) Structure, antiviral activity, and chemistry of acyclic nucleoside analogues. In Advances in Antiviral Drug Design, vol. 1, pp 87-177. Edited by E De Clercq. Greenwich: JAI Press.
23. Keller PM, Fyfe JA, Beauchamp L, Lubbers CM, Furman PA, Schaeffer HJ & Elion GB (1981) Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities. Biochemical Pharmacology 30:3071-3077.
24. Larsson A, Alenius S, Johansson NG & Öberg B (1983) Antiherpetic activity and mechanism of action of 9-(4-hydroxybutyl)guanine. Antiviral Research 3:77-86.
25. Larsson A, Stenberg K, Ericson A-C, Haglund U, Yisak W-A, Johansson NG, Öberg B & Datema R (1986) Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovir. Antimicrobial Agents & Chemotherapy 30:598-605.
26. Lazrek HB, Redwane N, Rochdi A, Barascut JL, Imbach J-L & De Clercq E (1995) Synthesis of acycloalkenyl derivatives of pyrimidines and purines. Nucleosides and Nucleotides 14:353-356.
27. Lewis AF, Drach JC, Fennewald SM, Huffman JH, Ptak RG, Sommadossi J-P, Revankar GR & Rando RF (1994) Inhibition of human cytomegalovirus in culture by alkenyl guanine analogs of the thiazolo[4,5-d]pyrimidine ring system. Antimicrobial Agents & Chemotherapy 38:2889-2895.
28. Lewis AF, Revankar GR, Fennewald SM, Huffman JH & Rando RF (1995) Thiazolo[4,5-d]pyrimidines. Part I. Synthesis and anti-human cytomegalovirus (HCMV) activity in vitro of certain alkyl derivatives. Journal of Heterocyclic Chemistry 32:547-556.
29. Martin JC, Dvorak CA, Smee DF, Matthews TR & Verheyden JPH (1983) 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine: a new potent and selective antiherpes agent. Journal of Medicinal Chemistry 26:759-761.
30. Meyers JD (1991) Prevention and treatment of cytomegalovirus infection. Annual Review of Medicine 42:179-187.
31. Miller WH & Miller RL (1980) Phosphorylation of acyclovir (acycloguanosine) monophosphate by GMP kinase. Journal of Biological Chemistry 255:7204-7207.
32. Nagahara K, Anderson JD, Kini GD, Dalley NK, Larson SB, Smee DF, Jin A, Sharma BS, Jolley WB, Robins RK & Cottam HB (1990) Thiazolo[4,5-d]-pyrimidine nucleosides. The synthesis of certain 3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidines as potential immunotherapeutic agents. Journal Medicinal Chemistry 33:407-415.
33. Neyts J, Andrei G, Snoeck R, Jahne G, Winkler I, Helsberg M, Balzarini J & De Clercq E (1994) The N-7-substituted acyclic nucleoside analog 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine is a potent and selective inhibitor of herpesvirus replication. Antimicrobial Agents & Chemotherapy 38:2710-2716.
34. Ojwang JO, Buckheit RW, Pommier Y, Mazumder A, De Vreese K, Este JA, Reymen D, Pallansch LA, Lackman-Smith C, Wallace TL, De Clercq E, McGrath MS & Rando RF (1995) T30177, an oligonucleotide stabilized by an intra-molecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1. Antimicrobial Agents & Chemotherapy 39:2426-2435.
35. Phadtare S, Kessel D, Corbett TH, Renis HE, Court BA & Zemlicka J (1991) Unsaturated and carbocyclic nucleoside analogues: synthesis, antitumor, and antiviral activity. Journal of Medicinal Chemistry 34:421-429.
36. Polis MA, Spooner KM, Baird BA, Manischewitz JG, Jaffe HS, Fisher PE, Falloon J, Davey Jr RT, Kovacs JA, Walker RE, Whitcup SM, Nussenblatt RB, Lane HC & Masur H (1995) Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria. Antimicrobial Agents & Chemotherapy 39:882-886.
37. Remy RJ & Secrist III JA (1985) Acyclic nucleosides other than acyclovir as potential antiviral agents. A bibliography. Nucleosides & Nucleotides 4:411-427.
38. Robins MJ & Hatfield PW (1982) Nucleic acid related compounds. 37. Convenient and high-yield syntheses of N-[(2-hydroxyethoxy)methyl]heterocycles as 'acyclic nucleoside' analogues. Canadian Journal of Chemistry 60:547-553.
39. Schaeffer HJ, Beauchamp L, de Miranda P, Elion GB, Bauer DJ & Collins P (1978) 9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group. Nature 272:583-585.
40. Sommadossi JP, Schinazi RF, Chu CK & Xie MY (1992) Comparison of cytotoxicity of the (-) and (+)-enantiomer of 2′,3′-dideoxy-3′-thiacytidine in normal human bone marrow progenitor cells. Biochemical Pharmacology 44:1921-1925.
41. Stanat SC, Reardon JE, Erice A, Jordan MC, Drew WL & Biron KK (1991) Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir. Antimicrobial Agents & Chemotherapy 35:2191-2197.
42. Tatarowicz WA, Lurain NS & Thompson KD (1992) A ganciclovir-resistant clinical isolate of human cytomegalovirus exhibiting cross-resistance to other DNA polymerase inhibitors. Journal of Infectious Diseases 166:904-907.